| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |